https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Clin. Cancer Res. 2003 Jan;9(1):285-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Clin. Cancer Res. 2003 Jan;9(1):285-942003-01-01 00:00:002003-01-01 00:00:00Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Clin. Cancer Res. 2003 Jan;9(1):174-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Clin. Cancer Res. 2003 Jan;9(1):174-802003-01-01 00:00:002020-06-23 09:43:48Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Int. J. Cancer 2003 Jan;103(1):73-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Int. J. Cancer 2003 Jan;103(1):73-832003-01-01 00:00:002020-06-23 09:43:21Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-932002-07-01 00:00:002020-06-23 09:44:19Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-11-01 / Blood 2000 Nov;96(9):3102-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-11-01 / Blood 2000 Nov;96(9):3102-82000-11-01 00:00:002000-11-01 00:00:00Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-06-01 / Clin. Cancer Res. 1999 Jun;5(6):1331-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-06-01 / Clin. Cancer Res. 1999 Jun;5(6):1331-81999-06-01 00:00:002019-02-15 08:39:12A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1997-04-01 / J. Clin. Oncol. 1997 Apr;15(4):1354-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1997-04-01 / J. Clin. Oncol. 1997 Apr;15(4):1354-661997-04-01 00:00:002020-06-23 09:47:26Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1996-07-01 / Int. J. Radiat. Oncol. Biol. Phys. 1996 Jul;35(4):731-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1996-07-01 / Int. J. Radiat. Oncol. Biol. Phys. 1996 Jul;35(4):731-441996-07-01 00:00:001996-07-01 00:00:00Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group
